NEWRON PHARMACEUT. EO-,20 financial statements, including revenue, expenses, profit, and loss

The total revenue of NP5 for the last semiannual is 3.40 M EUR, and it's 7.34% lower compared to the previous semiannual. The net income of H1 24 is -9.54 M EUR.